Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Sub-Potent Drug: Subpotent assay results during stability testing.
- Products
-
- Epinephrine Lidocaine HCL
- Company
- Imprimis NJOF, LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 6,880 vials
- About this recall
- Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01